/PRNewswire/ Geistlich Pharma North America Inc. is pleased to announce that our Executive Chairman, Dr. Andreas Geistlich, has been awarded the prestigious.
Fact.MR, a market research and competitive intelligence provider, projects the global dental membrane and bone graft substitutes market to have a positive outlook, expanding at a CAGR of above 8% across the 2021-2031 forecast period. Increasing prevalence of oral health diseases such as cavities and gum diseases is.